DRI Healthcare Trust (TSE:DHT.UN) Receives C$17.94 Consensus PT from Brokerages

DRI Healthcare Trust (TSE:DHT.UN) has earned an average rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is C$17.94.

DHT.UN has been the subject of a number of recent analyst reports. CIBC lowered their price target on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a report on Thursday, December 12th. Raymond James lowered their price objective on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th.

DRI Healthcare Trust Stock Performance

Shares of DHT.UN stock opened at C$11.83 on Tuesday. DRI Healthcare Trust has a 1-year low of C$10.39 and a 1-year high of C$17.43. The business has a 50-day moving average of C$11.99 and a 200 day moving average of C$12.57.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.